Fig. 7 | Scientific Reports

Fig. 7

From: Unveiling the potential anticancer activity of Spirulina maxima extract-nanoemulsion through in vitro and in vivo studies

Fig. 7

Liver tissue content of (a) catalase (CAT) and (b) malondialdehyde (MDA) activity in all studied groups. Comparisons among groups were analyzed using one-way ANOVA followed by a Least Significant Difference test. Values are presented as the mean ± standard error of the mean (n = 8). Different letters in the same histogram indicate significant differences (p < 0.05), whereas the same letters denote insignificance (p > 0.05). Normal: Mice without treatment; EAC: Ehrlich ascites-bearing mice without treatment; EAC + DOX: EAC-bearing mice treated with doxorubicin; EAC + SME: EAC-bearing mice with S. maxima extract treatment; EAC + SNE: EAC-bearing mice treated with silica nanoemulsion (SNE); EAC + SMNEC1: EAC-bearing mice treated with S. maxima extract nanoemulsion (SMNE) at 3225 µg/mL; EAC + SMNEC2: EAC-bearing mice treated with SMNE at 6451 µg/mL; EAC + SMNEC3: EAC-bearing mice treated with SMNE at 9677 µg/mL.

Back to article page